Read + Share
Amedeo Smart
Independent Medical Education
Sun N, Shen C, Zhang L, Wu X, et al. Hepatic Kruppel-like factor 16 (KLF16) targets PPARalpha to improve steatohepatitis and insulin resistance. Gut 2020 Nov 30. pii: gutjnl-2020-321774. doi: 10.1136/gutjnl-2020-321774.PMID: 33257471
Email
LinkedIn
Facebook
Twitter
Privacy Policy